Funding for this research was provided by:
National Cancer Institute (R01 CA1988887)
Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA206584)
Received: 19 February 2021
Accepted: 18 March 2021
First Online: 6 April 2021
: University of Hawaii and Cedars Sinai Local ethics review board approved. Subject gave written consent.
: Not applicable.
: Dr. Charles Rosser is an officer of Nonagen Bioscience. No financial or commercial conflicts of interest were declared by other co-authors. CJR is an officer of Nonagen Bioscience Corporation.